A systems level analysis of epileptogenesis-associated proteome alterations

Michael Keck1, Anna Fournier2, Fabio Gualtieri1

  • 1Institute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University (LMU), 80539 Munich, Germany.

Summary

This study reveals new molecular pathways in epilepsy development using systems-level proteomic analysis in a rat model. Findings offer potential biomarkers and therapeutic targets for epilepsy prevention and treatment.